Juwono Lindawati Sutedjo, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sutedjo’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C180691 · Current
Licensed to practise in California · since 2022 · expires 2028-07-31 · Saba University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$167,156
Medicare paid this office $167,156 for 802 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of both sides of head and neck blood flow | 265 | $40,819 | $154 |
| Return visit (30+ min) | 288 | $30,033 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 187 | $29,717 | $157 |
| Long return visit (40+ min) | 193 | $29,328 | $123 |
| New patient visit (60+ min) | 30 | $5,368 | $179 |
See all 22 services
| Ultrasound of both sides of head and neck blood flow | 265 | $40,819 | $154 |
| Return visit (30+ min) | 288 | $30,033 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 187 | $29,717 | $157 |
| Long return visit (40+ min) | 193 | $29,328 | $123 |
| New patient visit (60+ min) | 30 | $5,368 | $179 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $3,081 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,460 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 216 | $2,324 | $10 |
| Programming of dual lead pacemaker system | 21 | $2,206 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 36 | $1,940 | $21 |
| New patient visit (60+ min) | 11 | $1,792 | $163 |
| New patient visit (45+ min) | 13 | $1,715 | $132 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $1,629 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 171 | $1,319 | $6 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $894 | $30 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 24 | $519 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $447 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 18 | $240 | $13 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $226 | $19 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 22 | $216 | $10 |
| Heart rhythm recording of continous external ekg over 8-15 days | 23 | $213 | $9 |
| Electrocardiogram (ecg) 2-day continuous | 12 | $187 | $16 |
Who their Medicare patients are
802 Original Medicare patients in 2024. Average age 78 · Under 65 5% · 85 and older 23% · Women 51% · Also on Medicaid 26% · Health risk score 1.68. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 50% · Atrial fibrillation 39% · Diabetes 34% · Heart failure 31% · Chronic kidney disease 31% · COPD 22% · Depression 22% · Cancer 16% · Stroke 12% · Dementia 10%.
The office billed $781,946, Medicare allowed $246,872 and paid $167,156; for 2,115 services of 48 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 802 | 2,115 | 78 | 1.68 | $781,946 | $167,156 |
| 2023 | 520 | 1,296 | 77 | 1.63 | $371,188 | $111,164 |
| 2022 | 489 | 1,388 | 75 | 1.24 | $386,572 | $115,841 |
| 2021 | 605 | 1,539 | 74 | 1.21 | $425,343 | $131,584 |
| 2020 | 541 | 1,461 | 74 | 1.24 | $408,986 | $126,646 |
| 2019 | 472 | 1,333 | 75 | 1.48 | $384,221 | $124,630 |
| 2018 | 357 | 1,163 | 76 | 1.53 | $385,333 | $113,530 |
| 2017 | 1,186 | 1,946 | 74 | 1.65 | $361,725 | $76,671 |
| 2016 | 1,771 | 3,685 | 74 | 1.44 | $766,603 | $177,645 |
| 2015 | 1,636 | 3,186 | 74 | 1.43 | $621,357 | $147,173 |
| 2014 | 1,842 | 3,141 | 74 | 1.36 | $552,920 | $119,800 |
| 2013 | 671 | 1,005 | 74 | 1.45 | $199,433 | $41,216 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Return visit (30+ min) | 272 | $34,087 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $25,309 | $176 |
| Ultrasound of both sides of head and neck blood flow | 120 | $21,187 | $177 |
| Long return visit (40+ min) | 45 | $8,167 | $154 |
| New patient visit (45+ min) | 36 | $4,379 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 166 | $2,109 | $12 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $1,435 | $21 |
| Programming of dual lead pacemaker system | 17 | $1,423 | $62 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 39 | $920 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 17 | $865 | $51 |
| Blood test, clotting time | 18 | $332 | $4 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $323 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 37 | $302 | $7 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $256 | $21 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $219 | $15 |
| Electrocardiogram (ecg) 2-day continuous | 12 | $174 | $15 |
| Heart rhythm recording of continous external ekg over 8-15 days | 12 | $133 | $11 |
2022: 19 services
| Return visit (30+ min) | 127 | $20,785 | $101 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 109 | $18,785 | $171 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $17,495 | $427 |
| Ultrasound of both sides of head and neck blood flow | 62 | $9,627 | $155 |
| Injection, regadenoson, 0.1 mg | 39 | $7,754 | None |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 40 | $7,122 | $88 |
| New patient visit (45+ min) | 44 | $5,302 | $120 |
| Long return visit (40+ min) | 21 | $3,705 | $161 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 268 | $2,868 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 37 | $2,161 | $57 |
| Ultrasound scan of abdominal aorta | 16 | $1,958 | $122 |
| Short return visit (20+ min) | 26 | $1,957 | $67 |
| Injection, perflutren lipid microspheres, per ml | 20 | $1,403 | $35 |
| Electrocardiogram (ecg) 2-day continuous | 22 | $396 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 22 | $338 | $15 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 13 | $256 | $20 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $191 | $17 |
| Heart rhythm recording of continous external ekg over 8-15 days | 12 | $149 | $12 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 13 | $51 | $4 |
2021: 21 services
| Return visit (30+ min) | 140 | $25,651 | $107 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $18,326 | $458 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 92 | $16,575 | $178 |
| New patient visit (45+ min) | 77 | $10,505 | $136 |
| Ultrasound of both sides of head and neck blood flow | 49 | $8,321 | $166 |
| Injection, regadenoson, 0.1 mg | 39 | $7,520 | None |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 40 | $6,972 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 347 | $4,157 | $12 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 32 | $3,263 | $96 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 14 | $2,424 | $173 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 41 | $2,382 | $57 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,354 | $196 |
| Ultrasound scan of abdominal aorta | 18 | $2,215 | $123 |
| Short return visit (20+ min) | 25 | $2,199 | $81 |
| Ultrasound of leg arteries at rest and after exercise | 11 | $1,590 | $133 |
| Injection, perflutren lipid microspheres, per ml | 22 | $1,555 | $38 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $359 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $317 | $23 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $216 | $20 |
| Electrocardiogram (ecg) 2-day continuous | 13 | $214 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $181 | $15 |
2020: 19 services
| Return visit (30+ min) | 137 | $18,938 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 101 | $18,076 | $177 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $17,059 | $449 |
| Ultrasound of both sides of head and neck blood flow | 64 | $10,345 | $162 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 39 | $6,805 | $87 |
| Injection, regadenoson, 0.1 mg | 36 | $6,636 | None |
| Long return visit (40+ min) | 48 | $6,415 | $107 |
| New patient visit (45+ min) | 40 | $5,468 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 300 | $4,227 | $14 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $3,064 | $93 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 17 | $2,791 | $164 |
| Ultrasound scan of abdominal aorta | 19 | $2,419 | $127 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 38 | $2,123 | $56 |
| New patient visit (60+ min) | 12 | $2,079 | $173 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 19 | $2,046 | $108 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $1,468 | $70 |
| Injection, perflutren lipid microspheres, per ml | 18 | $1,380 | $38 |
| Short return visit (20+ min) | 16 | $1,079 | $67 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $706 | $64 |
2019: 22 services
| Long return visit (40+ min) | 109 | $22,513 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $13,042 | $169 |
| Ultrasound of both sides of head and neck blood flow | 71 | $12,029 | $165 |
| Return visit (30+ min) | 108 | $11,921 | $81 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 26 | $10,517 | $405 |
| New patient visit (60+ min) | 50 | $8,162 | $163 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 26 | $4,312 | $83 |
| New patient visit (45+ min) | 27 | $3,335 | $124 |
| Injection, regadenoson, 0.1 mg | 17 | $2,963 | None |
| Ultrasound of leg arteries or artery grafts | 12 | $2,728 | $227 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 25 | $2,636 | $101 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $2,098 | $161 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $1,968 | $73 |
| Ultrasound scan of abdominal aorta | 16 | $1,965 | $123 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 28 | $1,736 | $62 |
| Ultrasound of leg arteries at rest and after exercise | 13 | $1,689 | $130 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 129 | $1,667 | $13 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $1,627 | $148 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 26 | $1,310 | $50 |
| Injection, perflutren lipid microspheres, per ml | 14 | $1,065 | $38 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 13 | $236 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 12 | $95 | $8 |
2018: 20 services
| Long return visit (40+ min) | 101 | $21,038 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $15,542 | $175 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 33 | $14,344 | $435 |
| Ultrasound of both sides of head and neck blood flow | 50 | $8,676 | $167 |
| Return visit (30+ min) | 69 | $7,747 | $85 |
| New patient visit (60+ min) | 47 | $7,550 | $161 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 32 | $5,692 | $86 |
| Injection, regadenoson, 0.1 mg | 24 | $3,634 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,735 | $171 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,114 | $176 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $1,999 | $95 |
| Injection, perflutren lipid microspheres, per ml | 22 | $1,628 | $37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 28 | $1,541 | $55 |
| New patient visit (45+ min) | 11 | $1,433 | $130 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,346 | $71 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,239 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,054 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 65 | $944 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $321 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $304 | $23 |
2017: 17 services
| Return visit (30+ min) | 243 | $14,563 | $50 |
| Long return visit (40+ min) | 142 | $14,115 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 221 | $10,231 | $46 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 106 | $6,460 | $60 |
| New patient visit (45+ min) | 50 | $4,674 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 422 | $2,871 | $6 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $2,653 | $62 |
| New patient visit (60+ min) | 20 | $2,565 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,141 | $165 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 173 | $1,982 | $11 |
| Return visit (30+ min) | 31 | $1,710 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 80 | $1,283 | $16 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 17 | $785 | $46 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 37 | $656 | $18 |
| Electrocardiogram (ecg) 2-day continuous | 11 | $180 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $137 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 19 | $109 | $6 |
2016: 33 services
| Return visit (30+ min) | 468 | $38,499 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 517 | $25,522 | $47 |
| Long return visit (40+ min) | 216 | $21,457 | $83 |
| New patient visit (45+ min) | 141 | $14,009 | $99 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 179 | $10,829 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,620 | $162 |
| Critical care, first 30-74 minutes | 24 | $7,004 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $6,160 | $78 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 85 | $5,378 | $63 |
| New patient visit (60+ min) | 37 | $4,381 | $118 |
| Ultrasound of heart with probe in esophagus, with report | 44 | $4,238 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 528 | $3,800 | $6 |
| Return visit (30+ min) | 31 | $3,167 | $83 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 269 | $3,029 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $2,626 | $175 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 42 | $2,219 | $53 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 102 | $2,077 | $20 |
| Long return visit (40+ min) | 18 | $1,738 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,482 | $53 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,155 | $58 |
| External shock to heart to regulate heart beat | 11 | $1,049 | $95 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 50 | $948 | $19 |
| Short return visit (20+ min) | 20 | $777 | $39 |
| New patient visit (30+ min) | 13 | $677 | $52 |
| Ultrasound of heart blood flow, valves and chambers | 44 | $645 | $15 |
| Electrocardiogram (ecg) 2-day continuous | 25 | $517 | $21 |
| Ultrasound of heart, follow-up | 23 | $503 | $19 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 19 | $403 | $21 |
| 3d radiographic procedure | 33 | $246 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 29 | $190 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 19 | $128 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 50 | $124 | $2 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 16 | $102 | $6 |
2015: 26 services
| Return visit (30+ min) | 432 | $35,600 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 375 | $17,994 | $47 |
| Long return visit (40+ min) | 170 | $17,516 | $81 |
| New patient visit (45+ min) | 146 | $14,560 | $100 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 127 | $8,106 | $63 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 135 | $8,036 | $60 |
| New patient visit (60+ min) | 49 | $6,090 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,035 | $159 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 601 | $4,021 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $3,838 | $83 |
| Critical care, first 30-74 minutes | 18 | $3,612 | $181 |
| Return visit (30+ min) | 31 | $3,002 | $79 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 251 | $2,722 | $11 |
| Ultrasound of heart with probe in esophagus, with report | 26 | $2,513 | $97 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 39 | $1,995 | $51 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 83 | $1,782 | $21 |
| Short return visit (20+ min) | 33 | $1,379 | $38 |
| Long return visit (40+ min) | 11 | $1,129 | $94 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 44 | $890 | $20 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $695 | $58 |
| Ultrasound of heart blood flow, valves and chambers | 26 | $382 | $15 |
| Electrocardiogram (ecg) 2-day continuous | 16 | $326 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $322 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 27 | $143 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 23 | $114 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $75 | $3 |
2014: 31 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 410 | $20,109 | $48 |
| Long return visit (40+ min) | 163 | $18,405 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $10,923 | $161 |
| Return visit (30+ min) | 129 | $9,105 | $61 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 136 | $7,960 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 897 | $6,774 | $7 |
| New patient visit (45+ min) | 69 | $6,359 | $92 |
| New patient visit (60+ min) | 37 | $4,790 | $129 |
| Ultrasound of heart with probe in esophagus, with report | 56 | $4,705 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $3,865 | $82 |
| New patient visit (30+ min) | 56 | $3,171 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 272 | $3,015 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $2,683 | $57 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 39 | $2,438 | $63 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 43 | $2,370 | $55 |
| Short return visit (20+ min) | 34 | $1,427 | $41 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,316 | $110 |
| External shock to heart to regulate heart beat | 13 | $1,261 | $97 |
| Ultrasound of heart blood flow, valves and chambers | 53 | $791 | $14 |
| Ultrasound of heart, follow-up | 22 | $486 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 22 | $464 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 19 | $380 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 34 | $368 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $227 | $16 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 13 | $187 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 58 | $168 | $3 |
| 3d radiographic procedure | 17 | $134 | $8 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 12 | $125 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $113 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $109 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 14 | $88 | $6 |
2013: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 199 | $9,648 | $48 |
| Long return visit (40+ min) | 75 | $7,050 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,149 | $156 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 46 | $2,827 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 318 | $2,341 | $6 |
| New patient visit (45+ min) | 23 | $2,327 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $1,909 | $80 |
| New patient visit (60+ min) | 13 | $1,688 | $130 |
| Return visit (30+ min) | 20 | $1,196 | $60 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $963 | $80 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $720 | $65 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 11 | $548 | $50 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 48 | $539 | $11 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $244 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $170 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $41 | $3 |
Medicaid work
$11,775 in 2024
Medicaid paid $11,775 for 448 billed services this clinician did in 2024, up to 178 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 80 | $3,237 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 215 | $2,883 |
| Return visit (30+ min) | 96 | $2,840 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 13 | $1,950 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 44 | $865 |
| 2024 | 448 | 5 | 178 | $11,775 |
| 2023 | 372 | 5 | 48 | $13,997 |
| 2022 | 281 | 2 | 59 | $1,988 |
| 2021 | 257 | 2 | 32 | $1,645 |
| 2020 | 175 | 2 | 28 | $1,563 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 47 | $6,796 |
| Return visit (30+ min) | 134 | $3,340 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 55 | $1,711 |
| New patient visit (45+ min) | 15 | $1,075 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 121 | $1,074 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 214 | $1,319 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 67 | $669 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 239 | $1,426 |
| Return visit (30+ min) | 18 | $219 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 162 | $1,119 |
| Return visit (30+ min) | 13 | $444 |
Drugs they prescribed that Part D paid
$436,249
Pharmacies billed $436,249 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,967) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,641 generic and 326 brand-name prescriptions · $436,249 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 168 | $235,217 | $1,400 |
| Xarelto | 50 | $73,058 | $1,461 |
| Entresto | 36 | $56,109 | $1,559 |
| Repatha Sureclick | 25 | $15,624 | $625 |
| Diltiazem 24hr Er (Cd) | 50 | $3,992 | $80 |
See all 33 drugs
| Eliquis | 168 | $235,217 | $1,400 |
| Xarelto | 50 | $73,058 | $1,461 |
| Entresto | 36 | $56,109 | $1,559 |
| Repatha Sureclick | 25 | $15,624 | $625 |
| Diltiazem 24hr Er (Cd) | 50 | $3,992 | $80 |
| Metoprolol | 238 | $3,979 | $17 |
| Ranolazine Er | 16 | $3,068 | $192 |
| Atorvastatin | 255 | $2,960 | $12 |
| Rosuvastatin | 61 | $1,505 | $25 |
| Losartan | 85 | $1,228 | $14 |
| Verapamil Er | 30 | $1,088 | $36 |
| Clopidogrel | 53 | $994 | $19 |
| Potassium Chloride | 23 | $926 | $40 |
| Ezetimibe | 26 | $923 | $36 |
| Amlodipine Besylate | 125 | $898 | $7 |
| Diltiazem 24hr Er | 14 | $815 | $58 |
| Valsartan | 13 | $710 | $55 |
| Carvedilol | 75 | $687 | $9 |
| Lisinopril | 78 | $629 | $8 |
| Amiodarone | 11 | $536 | $49 |
| Benazepril | 32 | $452 | $14 |
| Hydralazine | 40 | $449 | $11 |
| Digoxin | 11 | $404 | $37 |
| Isosorbide Mononitrate Er | 20 | $404 | $20 |
| Spironolactone | 26 | $335 | $13 |
| Furosemide | 47 | $320 | $7 |
| Nitroglycerin | 19 | $299 | $16 |
| Metoprolol | 51 | $282 | $6 |
| Hydrochlorothiazide | 32 | $276 | $9 |
| Warfarin | 28 | $275 | $10 |
| Triamterene-Hydrochlorothiazid | 11 | $202 | $18 |
| Simvastatin | 25 | $137 | $5 |
| Atenolol | 11 | $107 | $10 |
Year by year
| 2024 | 1,967 | 357 | 0% (0) | 17% | $436,249 |
| 2023 | 759 | 306 | 0% (0) | 17% | $165,837 |
| 2022 | 1,232 | 252 | 0% (0) | 15% | $203,056 |
| 2021 | 1,166 | 226 | 0% (0) | 16% | $179,650 |
| 2020 | 949 | 176 | 0% (0) | 15% | $116,270 |
| 2019 | 791 | 166 | 0% (0) | 16% | $89,809 |
| 2018 | 704 | 175 | 0% (0) | 21% | $73,505 |
| 2017 | 2,031 | 342 | 0% (0) | 19% | $119,471 |
| 2016 | 2,720 | 375 | 0% (0) | None | $127,950 |
| 2015 | 1,562 | 251 | None | None | $56,328 |
| 2014 | 816 | 142 | 0% (0) | None | $33,816 |
| 2013 | 92 | 30 | 0% (0) | 13% | $4,743 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 59 | $87,291 | $1,480 |
| Entresto | 29 | $30,665 | $1,057 |
| Xarelto | 12 | $20,028 | $1,669 |
| Metoprolol | 106 | $1,925 | $18 |
| Atorvastatin | 82 | $1,340 | $16 |
| Diltiazem 24hr Er (Cd) | 18 | $657 | $36 |
| Rosuvastatin | 23 | $539 | $23 |
| Hydralazine | 21 | $532 | $25 |
| Losartan | 27 | $463 | $17 |
| Amlodipine Besylate | 44 | $417 | $9 |
| Clopidogrel | 16 | $346 | $22 |
| Potassium Chloride | 14 | $331 | $24 |
| Lisinopril | 27 | $312 | $12 |
| Furosemide | 36 | $280 | $8 |
| Ezetimibe | 13 | $266 | $20 |
| Carvedilol | 21 | $241 | $11 |
| Isosorbide Mononitrate Er | 14 | $235 | $17 |
| Benazepril | 11 | $183 | $17 |
| Spironolactone | 19 | $160 | $8 |
| Metoprolol | 17 | $110 | $6 |
2022: 24 drugs
| Eliquis | 118 | $156,911 | $1,330 |
| Metoprolol | 214 | $3,725 | $17 |
| Diltiazem 24hr Er (Cd) | 38 | $1,584 | $42 |
| Isosorbide Mononitrate Er | 46 | $1,205 | $26 |
| Potassium Chloride | 45 | $1,057 | $23 |
| Hydralazine | 38 | $991 | $26 |
| Atorvastatin | 88 | $778 | $9 |
| Carvedilol | 47 | $767 | $16 |
| Diltiazem 24hr Er | 16 | $699 | $44 |
| Furosemide | 98 | $679 | $7 |
| Losartan | 71 | $648 | $9 |
| Diltiazem | 20 | $606 | $30 |
| Torsemide | 17 | $513 | $30 |
| Clopidogrel | 20 | $512 | $26 |
| Amlodipine Besylate | 98 | $466 | $5 |
| Rosuvastatin | 17 | $328 | $19 |
| Dilt-Xr | 11 | $217 | $20 |
| Spironolactone | 24 | $214 | $9 |
| Atenolol | 15 | $175 | $12 |
| Simvastatin | 21 | $122 | $6 |
| Lisinopril | 27 | $117 | $4 |
| Warfarin | 12 | $111 | $9 |
| Clonidine | 11 | $74 | $7 |
| Ezetimibe | 11 | $67 | $6 |
2021: 21 drugs
| Eliquis | 104 | $112,524 | $1,082 |
| Xarelto | 30 | $40,618 | $1,354 |
| Metoprolol | 237 | $4,574 | $19 |
| Diltiazem 24hr Er (Cd) | 45 | $2,243 | $50 |
| Hydralazine | 58 | $1,540 | $27 |
| Isosorbide Mononitrate Er | 50 | $1,264 | $25 |
| Torsemide | 19 | $812 | $43 |
| Potassium Chloride | 34 | $740 | $22 |
| Atorvastatin | 62 | $593 | $10 |
| Losartan | 52 | $531 | $10 |
| Furosemide | 78 | $528 | $7 |
| Carvedilol | 41 | $515 | $13 |
| Amlodipine Besylate | 107 | $461 | $4 |
| Rosuvastatin | 18 | $426 | $24 |
| Amiodarone | 12 | $365 | $30 |
| Clopidogrel | 14 | $179 | $13 |
| Lisinopril | 37 | $149 | $4 |
| Clonidine | 17 | $141 | $8 |
| Warfarin | 15 | $134 | $9 |
| Spironolactone | 18 | $108 | $6 |
| Simvastatin | 15 | $50 | $3 |
2020: 20 drugs
| Eliquis | 67 | $59,816 | $893 |
| Xarelto | 28 | $29,957 | $1,070 |
| Metoprolol | 185 | $6,307 | $34 |
| Diltiazem 24hr Er (Cd) | 31 | $1,458 | $47 |
| Potassium Chloride | 36 | $1,371 | $38 |
| Isosorbide Mononitrate Er | 40 | $1,181 | $30 |
| Hydralazine | 29 | $888 | $31 |
| Atorvastatin | 64 | $811 | $13 |
| Furosemide | 73 | $585 | $8 |
| Amlodipine Besylate | 84 | $522 | $6 |
| Rosuvastatin | 15 | $471 | $31 |
| Amiodarone | 14 | $443 | $32 |
| Clopidogrel | 25 | $382 | $15 |
| Spironolactone | 14 | $261 | $19 |
| Losartan | 23 | $204 | $9 |
| Carvedilol | 23 | $187 | $8 |
| Lisinopril | 31 | $165 | $5 |
| Atenolol | 12 | $158 | $13 |
| Simvastatin | 15 | $149 | $10 |
| Metoprolol | 18 | $132 | $7 |
2019: 21 drugs
| Eliquis | 47 | $38,365 | $816 |
| Xarelto | 27 | $26,320 | $975 |
| Metoprolol | 110 | $3,668 | $33 |
| Bystolic | 11 | $1,618 | $147 |
| Potassium Chloride | 41 | $1,287 | $31 |
| Isosorbide Mononitrate Er | 39 | $1,155 | $30 |
| Torsemide | 23 | $1,063 | $46 |
| Cartia Xt | 14 | $692 | $49 |
| Atorvastatin | 40 | $653 | $16 |
| Hydralazine | 37 | $558 | $15 |
| Diltiazem 24hr Er (Cd) | 11 | $459 | $42 |
| Furosemide | 65 | $439 | $7 |
| Midodrine | 12 | $437 | $36 |
| Amlodipine Besylate | 60 | $377 | $6 |
| Clopidogrel | 17 | $302 | $18 |
| Losartan | 31 | $286 | $9 |
| Amiodarone | 14 | $273 | $20 |
| Spironolactone | 15 | $255 | $17 |
| Metoprolol | 21 | $200 | $10 |
| Carvedilol | 16 | $178 | $11 |
| Lisinopril | 29 | $156 | $5 |
2018: 17 drugs
| Xarelto | 45 | $29,955 | $666 |
| Eliquis | 39 | $26,203 | $672 |
| Metoprolol | 95 | $3,230 | $34 |
| Cartia Xt | 20 | $1,377 | $69 |
| Potassium Chloride | 31 | $974 | $31 |
| Atorvastatin | 30 | $572 | $19 |
| Amlodipine Besylate | 68 | $461 | $7 |
| Amiodarone | 27 | $437 | $16 |
| Furosemide | 58 | $417 | $7 |
| Losartan | 46 | $381 | $8 |
| Isosorbide Mononitrate Er | 19 | $354 | $19 |
| Carvedilol | 28 | $307 | $11 |
| Clopidogrel | 20 | $295 | $15 |
| Metoprolol | 20 | $152 | $8 |
| Lisinopril | 18 | $141 | $8 |
| Spironolactone | 13 | $120 | $9 |
| Simvastatin | 17 | $69 | $4 |
2017: 26 drugs
| Xarelto | 85 | $44,914 | $528 |
| Eliquis | 34 | $17,554 | $516 |
| Metoprolol | 305 | $8,155 | $27 |
| Ranexa | 16 | $7,714 | $482 |
| Potassium Chloride | 118 | $3,222 | $27 |
| Isosorbide Mononitrate Er | 61 | $1,433 | $23 |
| Atorvastatin | 80 | $1,307 | $16 |
| Amlodipine Besylate | 213 | $1,143 | $5 |
| Torsemide | 45 | $1,129 | $25 |
| Rosuvastatin | 16 | $1,084 | $68 |
| Clopidogrel | 82 | $865 | $11 |
| Losartan | 129 | $848 | $7 |
| Diltiazem 24hr Er | 36 | $786 | $22 |
| Metoprolol | 106 | $691 | $7 |
| Simvastatin | 80 | $621 | $8 |
| Cartia Xt | 19 | $621 | $33 |
| Pravastatin | 12 | $617 | $51 |
| Furosemide | 127 | $566 | $4 |
| Carvedilol | 71 | $521 | $7 |
| Lisinopril | 79 | $452 | $6 |
| Spironolactone | 64 | $430 | $7 |
| Nitroglycerin | 11 | $233 | $21 |
| Amiodarone | 23 | $211 | $9 |
| Hydralazine | 11 | $180 | $16 |
| Benazepril | 11 | $70 | $6 |
| Hydrochlorothiazide | 16 | $45 | $3 |
2016: 37 drugs
| Xarelto | 60 | $28,332 | $472 |
| Pradaxa | 21 | $13,488 | $642 |
| Ranexa | 27 | $11,633 | $431 |
| Metoprolol | 436 | $9,985 | $23 |
| Crestor | 14 | $7,953 | $568 |
| Brilinta | 16 | $7,887 | $493 |
| Eliquis | 11 | $4,738 | $431 |
| Potassium Chloride | 124 | $4,242 | $34 |
| Benicar | 12 | $3,767 | $314 |
| Atorvastatin | 123 | $2,147 | $17 |
| Isosorbide Dinitrate | 14 | $1,726 | $123 |
| Amlodipine Besylate | 299 | $1,613 | $5 |
| Clopidogrel | 115 | $1,484 | $13 |
| Fenofibrate | 16 | $1,477 | $92 |
| Isosorbide Mononitrate Er | 71 | $1,466 | $21 |
| Losartan | 188 | $1,390 | $7 |
| Torsemide | 52 | $1,324 | $25 |
| Pravastatin | 35 | $898 | $26 |
| Diltiazem 24hr Er | 27 | $839 | $31 |
| Cartia Xt | 29 | $777 | $27 |
| Metoprolol | 98 | $760 | $8 |
| Carvedilol | 83 | $703 | $8 |
| Lisinopril | 115 | $629 | $5 |
| Furosemide | 203 | $617 | $3 |
| Simvastatin | 66 | $605 | $9 |
| Digoxin | 17 | $541 | $32 |
| Nitrostat | 13 | $421 | $32 |
| Spironolactone | 57 | $399 | $7 |
| Bisoprolol | 14 | $377 | $27 |
| Nitroglycerin Patch | 12 | $325 | $27 |
| Hydralazine | 27 | $305 | $11 |
| Amiodarone | 34 | $266 | $8 |
| Klor-Con M20 | 13 | $262 | $20 |
| Hydrochlorothiazide | 46 | $185 | $4 |
| Atenolol | 12 | $126 | $11 |
| Warfarin | 18 | $116 | $6 |
| Sotalol | 13 | $90 | $7 |
2015: 26 drugs
| Metoprolol | 340 | $7,980 | $23 |
| Ranexa | 13 | $6,907 | $531 |
| Xarelto | 13 | $4,847 | $373 |
| Crestor | 12 | $3,309 | $276 |
| Brilinta | 11 | $2,768 | $252 |
| Atorvastatin | 60 | $1,204 | $20 |
| Isosorbide Mononitrate Er | 37 | $1,129 | $31 |
| Potassium Chloride | 30 | $920 | $31 |
| Pravastatin | 29 | $831 | $29 |
| Losartan | 116 | $804 | $7 |
| Amlodipine Besylate | 136 | $680 | $5 |
| Nitroglycerin Patch | 23 | $589 | $26 |
| Clopidogrel | 64 | $572 | $9 |
| Fenofibrate | 12 | $524 | $44 |
| Cartia Xt | 22 | $446 | $20 |
| Metoprolol | 65 | $435 | $7 |
| Carvedilol | 61 | $428 | $7 |
| Furosemide | 104 | $403 | $4 |
| Simvastatin | 54 | $391 | $7 |
| Lisinopril | 63 | $371 | $6 |
| Torsemide | 20 | $315 | $16 |
| Warfarin | 26 | $225 | $9 |
| Spironolactone | 25 | $130 | $5 |
| Klor-Con M20 | 12 | $124 | $10 |
| Sotalol | 12 | $67 | $6 |
| Omeprazole | 11 | $39 | $4 |
2014: 16 drugs
| Ranexa | 11 | $5,197 | $472 |
| Metoprolol | 131 | $3,869 | $30 |
| Nitroglycerin Patch | 25 | $986 | $39 |
| Pravastatin | 26 | $761 | $29 |
| Metoprolol | 104 | $636 | $6 |
| Isosorbide Mononitrate Er | 17 | $325 | $19 |
| Amlodipine Besylate | 70 | $318 | $5 |
| Simvastatin | 30 | $269 | $9 |
| Clopidogrel | 29 | $259 | $9 |
| Warfarin | 34 | $259 | $8 |
| Carvedilol | 50 | $245 | $5 |
| Diltiazem 24hr Er | 11 | $209 | $19 |
| Furosemide | 36 | $138 | $4 |
| Lisinopril | 38 | $138 | $4 |
| Spironolactone | 17 | $99 | $6 |
| Sotalol | 12 | $81 | $7 |
2013: 1 drug
| Metoprolol | 13 | $378 | $29 |
Money from drug and device companies
$224 in 2024
| 2024 | 7 | 9 | None | $224 |
| 2023 | 5 | 8 | None | $211 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Bodyguardian | $50 | 2 payments
|
| Artivion | Cryovalve Sg Pulmonary Human Heart Valve | $36 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $34 | 2 payments
|
| Amgen | Repatha | $33 | 1 payment
|
| Pfizer | Eliquis | $31 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $23 | 1 payment
|
See all 9 published payments
| Novartis Pharmaceuticals | Meals · 2024-07-25 | Entresto | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-07-10 | Farxiga | $16 |
| Artivion | Meals · 2024-05-13 | Cryovalve Sg Pulmonary Human Heart Valve | $36 |
| Boston Scientific | Meals · 2024-04-02 | Watchman Flx | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2024-03-19 | Lifevest | $23 |
| Pfizer | Meals · 2024-03-06 | Eliquis | $31 |
| Boston Scientific | Meals · 2024-02-22 | Bodyguardian | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-02-20 | Farxiga | $18 |
| Amgen | Meals · 2024-01-23 | Repatha | $33 |
See earlier years (2023)
2023: $211
| E.R. Squibb & Sons L.L.C. | Camzyos | $98 | 3 payments
|
| Amgen | Repatha | $53 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $31 | 1 payment
|
| Boston Scientific | Watchman Flx | $22 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $6 | 1 payment
|
Professional record
- NPI
- 1114072980
- Licence
- CA C180691, MA 228744, MT 21983California C180691: Current · expires 2028-07-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-01-24
- NPI last updated
- 2024-09-18
- NPI record certified
- 2024-09-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 141 Lynch Creek Way Ste C, Petaluma, CA, 94954 · 1101 Madison St Ste 301, Seattle, WA, 98104
This office lists an electronic records connection.